Figure 7.
Intracellular accumulation of DNR in K562/A02 cells after treatment with different agent for 48 hours.
Notes: A) control (K562/A02); B) K562/A02 incubated with 1.0 μg/mL DNR; C) K562/A02 incubated with 1.0 μg/mL DNR and 10 μg/mL MNP (Fe3O4); D) K562/A02 incubated with 1.0 μg/mL DNR and PGY1–2; E) K562/A02 incubated with 1.0 μg/mL DNR, 10 μg/mL MNP (Fe3O4) and PGY1–2.
Abbreviations: MNP (Fe3O4), magnetic nanoparticles of Fe3O4; DNR, daunorubicin.